Delivery Order SPE2DB22D7065-SPE2DB25FH2LL
Award Date
4/28/25
Potential Completion Date
5/19/25
Potential Value
$1.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $3,203.98 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the delivery of 4,565,717,648 PROQUAD VIALS, with a completion date of September 25, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the supply of a comprehensive...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,568,032,217 units of the PROQUAD VIALS pharmaceutical product. The contract has a ceiling value of $3,308.68 and a period of performance through May 13, 2025. The award was made on April 22, 2025 and does not utilize any set-aside designations, indicating open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds a...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for 4,563,910,641 PROQUAD VIALS. The delivery order has a completion date of March 27, 2024 and a potential value of $2,557.96. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 from DLA, which serves as the primary vehicle for the company to provide...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of PROQUAD VIALS, a medical product, with a ceiling value of $8,629.89 and a period of performance through July 2, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. The...
This is a $9,925.98 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of PROQUAD VIALS, a medical product, with a period of performance through February 18, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC provides...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4,565,772,992 PROQUAD vaccine vials. The fixed-price contract has a ceiling value of $1,570.54 and an ultimate completion date of October 1, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for delivering a range of...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of PROQUAD vials, a pharmaceutical product, with a potential value of $4,159.95 and a completion date of March 12, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of PROQUAD VIALS, a pharmaceutical product, with a ceiling value of $1,601.99 and a performance period through April 11, 2024. This delivery order is part of a larger indefinite delivery contract...
This is a delivery order contract award to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of 4565717654 PROQUAD VIALS. The contract has an ultimate completion date of September 24, 2024 and a ceiling value of $6,585.64. It is a firm fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, is the prime contractor for this award, which is part of a larger Indefinite Delivery...
This $6,282.16 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The order is for the delivery of PROQUAD VIALS, a medical product, with an ultimate completion date of October 2, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical for providing a comprehensive...